Trump's Covid treatment thrusts Limerick's Regeneron to centre stage

The company's experimental Covid treatment was administered to the President.

Regeneron, headquartered in New Yor with a major operations centre is Limerick, has begun human trials of a new antibody cocktail for Covid-19. Picture: Michael Nagle/Bloomberg

Regeneron Pharmaceuticals has found itself in the spotlight after President Donald Trump was treated with the company’s experimental antibody treatment for Covid-19, just days after the unveiling of promising preliminary trial results.

The biopharmaceutical company has a major operations facility in Limerick and is currently adding more than 400 jobs there in order to maximise capacity at its New York facility to produce large quantities of their Covid treatment.